Company / Net Income
Dyne Therapeutics, Inc. Net Income History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$317.4M
FY2024
5-year range
-$317.4M / -$59.4M
FY2020-FY2024
Trend
-34.5%
vs FY2023
Sector context
#180 of 214
Health Care
What the data says
Dyne Therapeutics, Inc.'s net income of -$317M is lower than 84% of companies in the Health Care sector (FY2024). Net Income has declined for 5 consecutive years, from -$15M in FY2019 to -$317M in FY2024.
Based on SEC 10-K filings.
-$317M in FY2024.
Declined from -$168M to -$317M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 214This company -$317.4M Sector average $442.7M
▼
-171.7% below sector average
Key checks
Key Insights
- Dyne Therapeutics, Inc.'s net income has declined for 5 consecutive years.
- In FY2024, net income decreased 34.5% year-over-year.
- Ranks #180 out of 214 companies in the Health Care sector.
- Peak net income was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$317.4M | -34.5% |
| FY2023 | -$235.9M | -40.4% |
| FY2022 | -$168.1M | -12.6% |
| FY2021 | -$149.3M | -151.2% |
| FY2020 | -$59.4M | -300.0% |
| FY2019 | -$14.9M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026